Table 2.
No | Operation | MAB | Preop PSA (ng/ml) | Probability of EPE (%) | D’amico classification | pT stage | Gleason score | Fluorescence intensity | Margin status | Heat Degeneration (pathological) | Linear length of surgical margin (mm) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | open | none | 5.8 | 19 | low | 2b | 4 + 5 | moderate | positive surgical margin | - | 8.2 |
2 | open | none | 42.57 | 27 | high | 3b | 5 + 4 | none | positive surgical margin | + | 1.5 |
3 | Laparoscopy | none | 21.15 | 59 | intermediate | 3a | 4 + 3 | none | positive surgical margin | - | 7.0 |
4 | Laparoscopy | none | 6.87 | 30 | low | 3b | 3 + 4 | none | Extraprostatic extension | - | 1.2 |
5 | Laparoscopy | none | 11.93 | 21 | high | 3a | 4 + 5 | none | Extraprostatic extension | - | 2.0 |
6 | Laparoscopy | none | 21.15 | 59 | intermediate | 3a | 4 + 3 | none | Extraprostatic extension | - | 3.3 |
MAB, Maximum androgen blockade, EPE; Extraprostatic extension